Page last updated: 2024-08-22

methylprednisolone hemisuccinate and metoclopramide

methylprednisolone hemisuccinate has been researched along with metoclopramide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Baethge, BA; Lidsky, MD1
Erlichman, C; Levitt, M; Osoba, D; Pater, JL; Willan, AR1
Cook, RJ1
Cook, RJ; Willan, AR1
Chan, IS; Li, HQ; Tang, ML; Tang, NS; Tian, GL1

Trials

1 trial(s) available for methylprednisolone hemisuccinate and metoclopramide

ArticleYear
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1986, Volume: 9, Issue:4

    Topics: Antineoplastic Agents; Anxiety; Gastrointestinal Diseases; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Sleep Stages; Vomiting

1986

Other Studies

5 other study(ies) available for methylprednisolone hemisuccinate and metoclopramide

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Intractable hiccups associated with high-dose intravenous methylprednisolone therapy.
    Annals of internal medicine, 1986, Volume: 104, Issue:1

    Topics: Adult; Hiccup; Humans; Infusions, Parenteral; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Metoclopramide; Middle Aged

1986
Interim analyses in 2 x 2 crossover trials.
    Biometrics, 1995, Volume: 51, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Biometry; Clinical Trials as Topic; Cross-Over Studies; Humans; Mathematics; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Research Design

1995
Design considerations in crossover trials with a single interim analysis and serial patient entry.
    Biometrics, 1996, Volume: 52, Issue:2

    Topics: Antineoplastic Agents; Biometry; Clinical Trials as Topic; Cross-Over Studies; Humans; Linear Models; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Randomized Controlled Trials as Topic; Time Factors

1996
Confidence-interval construction for rate ratio in matched-pair studies with incomplete data.
    Journal of biopharmaceutical statistics, 2014, Volume: 24, Issue:3

    Topics: Antiemetics; Clinical Trials as Topic; Confidence Intervals; Humans; Likelihood Functions; Matched-Pair Analysis; Methylprednisolone Hemisuccinate; Metoclopramide; Models, Statistical; Sample Size; Vomiting

2014